Eventide Asset Management - Q3 2022 holdings

$5.08 Billion is the total value of Eventide Asset Management's 138 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 25.0% .

 Value Shares↓ Weighting
RXDX SellPROMETHEUS BIOSCIENCES INC$157,513,000
+72.6%
2,669,255
-17.4%
3.10%
+58.8%
MTD BuyMETTLER TOLEDO INTERNATIONAL$132,873,000
-5.6%
122,563
+0.1%
2.61%
-13.2%
ASND  ASCENDIS PHARMA A/Ssponsored adr$123,809,000
+11.1%
1,199,0000.0%2.44%
+2.2%
KRTX SellKARUNA THERAPEUTICS INC$116,896,000
+49.2%
519,700
-16.1%
2.30%
+37.2%
PANW BuyPALO ALTO NETWORKS INC$114,501,000
+4.1%
699,074
+214.0%
2.25%
-4.2%
ARGX  ARGENX SEsponsored adr$112,764,000
-6.8%
319,4000.0%2.22%
-14.3%
TT BuyTRANE TECHNOLOGIES PLC$111,625,000
+18.7%
770,836
+6.5%
2.20%
+9.2%
ODFL BuyOLD DOMINION FREIGHT LINE IN$110,839,000
-2.9%
445,549
+0.1%
2.18%
-10.6%
TTD BuyTHE TRADE DESK INC$109,552,000
+43.2%
1,833,500
+0.4%
2.16%
+31.6%
WCN BuyWASTE CONNECTIONS INC$108,816,000
+9.2%
805,270
+0.2%
2.14%
+0.4%
CTAS SellCINTAS CORP$107,692,000
+1.8%
277,421
-2.0%
2.12%
-6.3%
ZI BuyZOOMINFO TECHNOLOGIES INC$105,512,000
+25.7%
2,532,698
+0.3%
2.08%
+15.7%
NEP BuyNEXTERA ENERGY PARTNERS LP$105,438,000
+9.7%
1,458,142
+12.5%
2.07%
+0.8%
DOCS BuyDOXIMITY INCcl a$103,089,000
+95.7%
3,411,287
+125.5%
2.03%
+80.1%
FIVN BuyFIVE9 INC$101,598,000
-10.7%
1,355,000
+8.6%
2.00%
-17.8%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$100,315,000
-2.1%
608,672
+0.1%
1.97%
-9.9%
ROP BuyROPER TECHNOLOGIES INC$96,337,000
+3.1%
267,872
+13.2%
1.90%
-5.2%
XMTR BuyXOMETRY INC$91,721,000
+92.5%
1,615,098
+15.0%
1.80%
+77.1%
GH  GUARDANT HEALTH INC$90,488,000
+33.4%
1,681,0000.0%1.78%
+22.8%
IDXX BuyIDEXX LABS INC$83,906,000
-7.0%
257,538
+0.1%
1.65%
-14.5%
LOW BuyLOWES COS INC$82,255,000
+7.6%
437,967
+0.1%
1.62%
-1.0%
DLO BuyDLOCAL LTD$80,919,000
-9.7%
3,943,403
+15.5%
1.59%
-17.0%
POOL  POOL CORP$78,630,000
-9.4%
247,1000.0%1.55%
-16.6%
NewBIOHAVEN LTD$74,894,000495,432
+100.0%
1.47%
KNBE SellKNOWBE4 INCcl a$67,993,000
+3.3%
3,267,317
-22.4%
1.34%
-4.9%
LNG SellCHENIERE ENERGY INC$67,174,000
+24.0%
404,882
-0.6%
1.32%
+14.1%
GLBE BuyGLOBAL E ONLINE LTD$66,990,000
+41.1%
2,503,371
+6.4%
1.32%
+29.9%
EXAS BuyEXACT SCIENCES CORP$60,671,000
+12.8%
1,867,365
+36.7%
1.19%
+3.8%
SPT  SPROUT SOCIAL INC$60,130,000
+4.5%
990,9430.0%1.18%
-3.9%
HZNP BuyHORIZON PHARMA PLC$60,108,000
+979.7%
971,200
+1291.4%
1.18%
+894.1%
HUBS SellHUBSPOT INC$58,039,000
-10.9%
214,865
-0.9%
1.14%
-18.1%
MDB BuyMONGODB INCcl a$57,416,000
+157.3%
289,160
+236.2%
1.13%
+136.9%
APTV BuyAPTIV PLC$56,323,000
-12.1%
720,147
+0.1%
1.11%
-19.2%
CCI BuyCROWN CASTLE INC$54,049,000
-8.2%
373,912
+7.0%
1.06%
-15.6%
ENTG BuyENTEGRIS INC$53,902,000
-9.5%
649,268
+0.4%
1.06%
-16.8%
DV NewDOUBLEVERIFY HLDGS INC$50,519,0001,847,144
+100.0%
0.99%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$50,367,000
+29.2%
1,791,800
+23.9%
0.99%
+18.8%
DHI SellD R HORTON INC$48,939,000
-5.4%
726,643
-7.0%
0.96%
-12.9%
GNRC  GENERAC HLDGS INC$48,044,000
-15.4%
269,7000.0%0.94%
-22.2%
ENPH  ENPHASE ENERGY INC$45,228,000
+42.1%
163,0000.0%0.89%
+30.7%
DDOG BuyDATADOG INC$45,068,000
-6.6%
507,635
+0.2%
0.89%
-14.1%
A  AGILENT TECHNOLOGIES INC$43,539,000
+2.3%
358,2000.0%0.86%
-5.8%
TREX  TREX CO INC$43,501,000
-19.3%
990,0000.0%0.86%
-25.7%
MPWR BuyMONOLITHIC PWR SYS INC$43,099,000
-4.8%
118,598
+0.6%
0.85%
-12.4%
COGT SellCOGENT BIOSCIENCES INC$42,685,000
-7.1%
2,860,892
-43.8%
0.84%
-14.5%
COLL  COLLEGIUM PHARMACEUTICAL INC$42,126,000
-9.6%
2,629,5930.0%0.83%
-16.9%
LRCX BuyLAM RESEARCH CORP$41,604,000
-14.0%
113,673
+0.2%
0.82%
-20.8%
FLYW BuyFLYWIRE CORPORATION$41,336,000
+1664.2%
1,800,367
+1254.5%
0.81%
+1526.0%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$40,309,000
+42.9%
1,861,000
+85.4%
0.79%
+31.5%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$38,687,000
-10.1%
1,236,0000.0%0.76%
-17.3%
CWEN BuyCLEARWAY ENERGY INCcl c$36,356,000
+23.9%
1,141,486
+35.5%
0.72%
+13.9%
ZYME  ZYMEWORKS INC$33,088,000
+16.0%
5,380,2000.0%0.65%
+6.7%
LSCC SellLATTICE SEMICONDUCTOR CORP$31,423,000
-0.4%
638,544
-1.8%
0.62%
-8.4%
IMVT  IMMUNOVANT INC$29,979,000
+43.1%
5,372,5120.0%0.59%
+31.7%
BPMC  BLUEPRINT MEDICINES CORP$28,893,000
+30.4%
438,5000.0%0.57%
+19.8%
ASML BuyASML HOLDING N V$28,695,000
-12.6%
69,086
+0.1%
0.56%
-19.5%
COUR BuyCOURSERA INC$28,618,000
-23.5%
2,654,716
+0.6%
0.56%
-29.6%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$28,235,000
-15.8%
411,827
+0.4%
0.56%
-22.6%
MASS Buy908 DEVICES INC$28,225,000
-8.5%
1,715,801
+14.5%
0.56%
-15.9%
NVT BuyNVENT ELECTRIC PLC$27,605,000
+2.5%
873,300
+1.6%
0.54%
-5.7%
VRSK  VERISK ANALYTICS INC$26,910,000
-1.5%
157,8000.0%0.53%
-9.4%
MIRM NewMIRUM PHARMACEUTICALS INC$26,788,0001,275,000
+100.0%
0.53%
BEPC  BROOKFIELD RENEWABLE CORPcl a sub vtg$25,328,000
-8.2%
775,0190.0%0.50%
-15.6%
NBIX  NEUROCRINE BIOSCIENCES INC$24,959,000
+9.0%
235,0000.0%0.49%
+0.2%
NDAQ BuyNASDAQ INC$24,782,000
+35.5%
437,225
+264.7%
0.49%
+24.8%
HASI  HANNON ARMSTRONG SUST INFR C$24,622,000
-20.9%
822,6640.0%0.48%
-27.3%
REXR SellREXFORD INDL RLTY INC$23,931,000
-17.1%
460,209
-8.2%
0.47%
-23.7%
STE BuySTERIS PLC$23,171,000
+0.2%
139,352
+24.2%
0.46%
-7.9%
APLS NewAPELLIS PHARMACEUTICALS INC$23,178,000339,355
+100.0%
0.46%
XENE BuyXENON PHARMACEUTICALS INC$23,147,000
+62.0%
641,200
+36.5%
0.46%
+48.7%
ANNX  ANNEXON INC$22,412,000
+63.9%
3,626,5080.0%0.44%
+51.0%
RGEN  REPLIGEN CORP$22,266,000
+15.2%
119,0000.0%0.44%
+6.1%
CDW BuyCDW CORP$22,273,000
+71.1%
142,700
+72.8%
0.44%
+57.6%
WMB BuyWILLIAMS COS INC$21,556,000
-3.8%
752,900
+4.9%
0.42%
-11.5%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$19,859,000
+38.6%
853,8000.0%0.39%
+27.8%
NARI BuyINARI MED INC$19,324,000
+360.6%
266,030
+331.2%
0.38%
+322.2%
IRTC BuyIRHYTHM TECHNOLOGIES INC$18,645,000
+489.1%
148,830
+408.0%
0.37%
+439.7%
WEC BuyWEC ENERGY GROUP INC$18,190,000
-5.9%
203,400
+5.9%
0.36%
-13.3%
NTLA NewINTELLIA THERAPEUTICS INC$17,851,000319,000
+100.0%
0.35%
FRC BuyFIRST REP BK SAN FRANCISCO C$17,235,000
-5.4%
132,015
+4.4%
0.34%
-13.1%
KLAC BuyKLA CORP$16,291,000
+16.0%
53,833
+22.3%
0.32%
+7.0%
SNPS SellSYNOPSYS INC$15,937,000
-6.6%
52,166
-7.1%
0.31%
-14.0%
ESI  ELEMENT SOLUTIONS INC$15,798,000
-8.6%
971,0000.0%0.31%
-15.9%
AESC BuyAES CORPunit 02/15/2024$15,129,000
+16.0%
171,200
+13.3%
0.30%
+6.8%
STRO  SUTRO BIOPHARMA INC$15,035,000
+6.5%
2,708,9750.0%0.30%
-2.0%
INSP BuyINSPIRE MED SYS INC$14,908,000
+256.4%
84,050
+267.0%
0.29%
+229.2%
NOVT SellNOVANTA INC$14,560,000
-57.1%
125,900
-55.0%
0.29%
-60.6%
PNR  PENTAIR PLC$14,237,000
-11.2%
350,4000.0%0.28%
-18.4%
MRTX BuyMIRATI THERAPEUTICS INC$14,219,000
+87.4%
203,600
+80.2%
0.28%
+72.8%
PRVA BuyPRIVIA HEALTH GROUP INC$14,168,000
+75.1%
415,985
+49.7%
0.28%
+61.3%
CMS SellCMS ENERGY CORP$14,103,000
-27.2%
242,158
-15.6%
0.28%
-33.1%
ISRG  INTUITIVE SURGICAL INC$14,058,000
-6.6%
75,0000.0%0.28%
-14.0%
VECT  VECTIVBIO HLDG AG$14,034,000
+11.1%
2,339,0440.0%0.28%
+2.2%
PRTA NewPROTHENA CORP PLC$13,945,000230,000
+100.0%
0.27%
SHLS  SHOALS TECHNOLOGIES GROUP INcl a$13,379,000
+30.8%
620,8320.0%0.26%
+20.1%
BEAM NewBEAM THERAPEUTICS INC$12,721,000267,025
+100.0%
0.25%
RARE NewULTRAGENYX PHARMACEUTICAL IN$12,663,000305,800
+100.0%
0.25%
SYY BuySYSCO CORP$12,523,000
-8.4%
177,100
+9.8%
0.25%
-15.8%
ARVN NewARVINAS INC$12,524,000281,500
+100.0%
0.25%
VCYT BuyVERACYTE INC$12,151,000
+46.1%
732,000
+75.1%
0.24%
+34.3%
IEX  IDEX CORP$11,671,000
+10.0%
58,4000.0%0.23%
+1.3%
ICPT  INTERCEPT PHARMACEUTICALS IN$11,160,000
+1.0%
800,0000.0%0.22%
-6.8%
SWAV BuySHOCKWAVE MED INC$11,039,000
+144.7%
39,700
+68.2%
0.22%
+126.0%
BAX  BAXTER INTL INC$10,697,000
-16.1%
198,6000.0%0.21%
-23.1%
YETI  YETI HLDGS INC$10,524,000
-34.1%
369,0000.0%0.21%
-39.3%
ADCT  ADC THERAPEUTICS SA$9,061,000
-39.4%
1,879,9590.0%0.18%
-44.4%
EHC NewENCOMPASS HEALTH CORP$8,797,000194,495
+100.0%
0.17%
ALXO NewALX ONCOLOGY HLDGS INC$8,632,000902,000
+100.0%
0.17%
PRAX  PRAXIS PRECISION MEDICINES I$7,986,000
-7.3%
3,518,0620.0%0.16%
-14.7%
WD  WALKER & DUNLOP INC$7,915,000
-13.1%
94,5350.0%0.16%
-20.0%
EVH  EVOLENT HEALTH INCcl a$7,786,000
+17.0%
216,7000.0%0.15%
+7.7%
ELS SellEQUITY LIFESTYLE PPTYS INC$7,754,000
-31.9%
123,385
-23.6%
0.15%
-37.3%
 GXO LOGISTICS INCORPORATED$7,713,000
-19.0%
220,0000.0%0.15%
-25.5%
APTVPRA SellAPTIV PLC5.5% cnv pfd a$7,436,000
-25.7%
78,500
-16.9%
0.15%
-31.8%
EGP  EASTGROUP PPTYS INC$7,332,000
-6.5%
50,8000.0%0.14%
-14.3%
OPCH  OPTION CARE HEALTH INC$6,971,000
+13.3%
221,5000.0%0.14%
+3.8%
BCAB NewBIOATLA INC$6,122,000795,000
+100.0%
0.12%
AJG NewGALLAGHER ARTHUR J & CO$5,810,00033,932
+100.0%
0.11%
 ROIVANT SCIENCES LTD$5,330,000
-20.9%
1,690,3000.0%0.10%
-27.1%
SNV SellSYNOVUS FINL CORP$5,232,000
+2.1%
139,487
-1.8%
0.10%
-6.4%
XPO  XPO LOGISTICS INC$5,120,000
-7.5%
115,0000.0%0.10%
-14.4%
IONS  IONIS PHARMACEUTICALS INC$4,865,000
+19.5%
110,0000.0%0.10%
+10.3%
ZTS NewZOETIS INCcl a$4,559,00030,747
+100.0%
0.09%
ARE SellALEXANDRIA REAL ESTATE EQ IN$4,533,000
-21.7%
32,335
-19.0%
0.09%
-28.2%
TALS  TALARIS THERAPEUTICS INC$4,106,000
-41.7%
1,561,0920.0%0.08%
-46.4%
FRLN  FREELINE THERAPEUTICS HLDGSsponsored ads$4,091,000
-20.8%
5,950,0000.0%0.08%
-27.9%
KALV NewKALVISTA PHARMACEUTICALS INC$4,008,000276,200
+100.0%
0.08%
SHW BuySHERWIN WILLIAMS CO$3,827,000
-7.6%
18,692
+1.0%
0.08%
-15.7%
PHVS  PHARVARIS N V$3,616,000
-63.7%
450,2510.0%0.07%
-66.7%
EQT NewEQT CORP$3,339,00081,934
+100.0%
0.07%
EPIX SellESSA PHARMA INC$2,841,000
-73.2%
1,561,251
-53.6%
0.06%
-75.3%
BuyARTERIS INC$2,637,000
+90.5%
396,021
+99.5%
0.05%
+73.3%
CMPX NewCOMPASS THERAPEUTICS INC$2,509,0001,100,399
+100.0%
0.05%
TRGP SellTARGA RES CORP$2,184,000
-65.5%
36,200
-65.9%
0.04%
-68.1%
 GUARDANT HEALTH INCnote 11/1$2,125,000
+17.7%
2,900,0000.0%0.04%
+7.7%
BILL NewBILL COM HLDGS INC$1,655,00012,500
+100.0%
0.03%
PLD SellPROLOGIS INC.$1,057,000
-81.9%
10,400
-79.0%
0.02%
-83.2%
WMS SellADVANCED DRAIN SYS INC DEL$1,088,000
-69.8%
8,752
-78.1%
0.02%
-72.7%
KBH ExitKB HOME$0-35,100
-100.0%
-0.02%
CIEN ExitCIENA CORP$0-32,000
-100.0%
-0.03%
MNDY ExitMONDAY COM LTD$0-20,409
-100.0%
-0.04%
SLAB ExitSILICON LABORATORIES INC$0-19,137
-100.0%
-0.06%
PHAT ExitPHATHOM PHARMACEUTICALS INC$0-336,223
-100.0%
-0.06%
DSGN ExitDESIGN THERAPEUTICS INC$0-281,569
-100.0%
-0.08%
LOB ExitLIVE OAK BANCSHARES INC$0-136,983
-100.0%
-0.10%
GRMN ExitGARMIN LTD$0-55,700
-100.0%
-0.12%
VITL ExitVITAL FARMS INC$0-950,092
-100.0%
-0.18%
NRIX ExitNURIX THERAPEUTICS INC$0-1,154,000
-100.0%
-0.31%
CGNX ExitCOGNEX CORP$0-359,000
-100.0%
-0.33%
CCXI ExitCHEMOCENTRYX INC$0-728,385
-100.0%
-0.39%
ExitDICE THERAPEUTICS INC$0-1,370,261
-100.0%
-0.44%
KURA ExitKURA ONCOLOGY INC$0-1,790,144
-100.0%
-0.70%
ExitDUOLINGO INC$0-378,375
-100.0%
-0.71%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-1,129,100
-100.0%
-3.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings